Medical Devices Startups
6,551 companies tagged Medical Devices, with their investors and founders.
Prevencio develops advanced diagnostic tests for cardiac risk assessment and personalized health management. The company serves healthcare providers and patients seeking early detection and prevention of cardiovascular and metabolic disease through AI-driven biomarker testing.
0 investors
Preventative Diagnostic Center operates a low-dose CT scanning facility offering full-body, heart, and lung scans for early detection of conditions such as heart disease and cancer, with results read by a board-certified radiologist. It serves residents seeking preventative health screening in Las Vegas, Nevada.
0 investors
Pristine Surgical is a medical device company that makes single-use endoscopes paired with cloud-based software for minimally invasive visualization. It sells to endoscopy suites through a subscription model with automated inventory management and transparent pricing.
0 investors
Product Creation Studio is a product design and development consultancy offering electrical, mechanical, and firmware engineering, industrial design, human factors, UX, quality engineering, and project management services. It serves R&D executives, corporate intrapreneurs, and startup CEOs as an extension of their teams, with expertise including regulated medical device development.
0 investors
Prolaio develops continuous, predictive heart data monitoring using high-density data capture and advanced analytics to support cardiovascular therapy development and patient care. It serves patients and drug developers in cardiology, aiming to replace episodic monitoring with real-world data and AI-based tools.
0 investors
Prolifagen develops microRNA (miR) technology to stimulate the regeneration of heart muscle damaged by myocardial infarction, aiming to prevent scar tissue formation and restore cardiac function. The company targets physicians and heart attack patients seeking solutions to prevent heart failure and recurrent cardiac events.
0 investors
PROMISS Diagnostics develops diagnostic tools that apply analytics to common blood tests to expand their diagnostic capability. The company focuses on affordable, accessible medical diagnostics in the healthcare and life sciences space.
0 investors
ProPhase Labs appears to operate multiple subsidiary companies including Nebula Genomics, ProPhase Biopharma, and TK Supplements, but detailed information about the company's primary business, products, and market focus is not available on this investor relations presentations page.
0 investors
Propria develops a patented system for producing and analyzing human engineered heart tissue (hEHT), generating detailed datasets on the contractile function of human cardiac tissue. It serves academic groups, pharmaceutical companies, and biotech and gene therapy firms.
0 investors
Protagenic Therapeutics develops therapeutic treatments focused on the body's stress response and healing processes for patients with psychological, physical, and medical conditions.
0 investors
Protaryx is a medical device company developing cardiac technology, led by a team including a cardiac surgeon and executives with device-industry backgrounds.
0 investors
Protera Health is a virtual musculoskeletal (MSK) care solution built on patient reported outcome measures (PROMs) to improve health outcomes and lower costs of care. Launched as a joint venture with Henry Ford Health, it delivers care through a clinician team focused on orthopedic value-based healthcare.
0 investors
ProtoLase provides laser processing services for organizations requiring clinical relevance and product efficiency in their manufacturing or product development processes.
0 investors
ProtoKinetix develops a proprietary anti-aging glycopeptide (AAGP®) designed to improve cell survival and viability, with applications across ophthalmology, dermatology, transplantation, and biomanufacturing. The company conducts research and clinical studies focused on cryopreservation and cell replacement therapies for chronic conditions.
0 investors
Protosthetics provides digital design and 3D-printing solutions for orthotics and prosthetics (O&P) products, working with clients through dedicated digital technicians. It offers a platform and hardware (Galileo) with ongoing upgrades for producing O&P devices.
0 investors
Provision Healthcare develops proton therapy systems and solutions for treating localized cancers, a non-invasive radiation treatment that targets cancer cells while limiting damage to surrounding healthy tissue. It works to expand access to proton therapy for cancer patients and care providers.
0 investors
Proxim develops a handheld point-of-care immunodiagnostic device that runs laboratory-grade blood tests near the patient using whole blood, with a low-cost disposable test cartridge. Its test menu covers women's health, sepsis, cardiology, and infectious disease, targeting hospital emergency departments in the USA and other clinical settings globally.
0 investors
Pupil.bio is a biotechnology company developing molecular diagnostics, with a focus on cancer detection and related genomic assay technologies. Its team's background centers on liquid biopsy and cancer panel development.
0 investors
Pure Scientific Technologies Inc. is a company presenting investor relations contact information on its site. The page does not describe the company's actual products or business activities.
0 investors
Pymedix develops medical AI software for radiation oncology, including Autofuse, a 3D deformable image registration tool, and automated machine perception technologies for radiotherapy. It serves the radiation oncology field with tools aimed at personalized medicine and data-driven care.
0 investors
Q'Apel Medical designs purpose-built devices for neurovascular and stroke care, developing tools focused on catheter access and navigation through complex vascular pathways. It develops these solutions in collaboration with neurovascular clinicians to address unmet clinical needs during stroke interventions.
0 investors
Qentoros develops peptide biologic therapeutics for veterinary medicine through its Q-Biologics platform, with the first product BIO-PLY™ in FDA development for infectious, inflammatory, and degenerative diseases.
0 investors
QHSLab, Inc. develops a cloud-based digital medicine platform for independent primary care physicians to deliver virtual care, personalized medicine, and chronic disease management through reimbursable software tools. The company targets solo and independent practitioners seeking to increase revenue and improve clinical outcomes in value-based healthcare.
0 investors
QuadVantage manufactures specialized surgical instruments for quadriceps tendon grafting procedures, designed to improve graft consistency, reduce complications, and accelerate recovery in orthopedic ACL reconstruction. The company's product line includes reusable bone guides, scalpels, harvesters, and disposable blades for use by orthopedic surgeons.
0 investors